Silence Therapeutics Plc Stock Volatility Indicators Average True Range

SLN Stock  USD 7.21  0.20  2.85%   
Silence Therapeutics volatility indicators tool provides the execution environment for running the Average True Range indicator and other technical functions against Silence Therapeutics. Silence Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volatility indicators indicators. As with most other technical indicators, the Average True Range indicator function is designed to identify and follow existing trends. Silence Therapeutics volatility indicators enable investors to predict price movements based on how different True Range indicators change over time. Please specify Time Period to run this model.

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Silence Therapeutics PLC volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Silence Therapeutics Technical Analysis Modules

Most technical analysis of Silence Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Silence from various momentum indicators to cycle indicators. When you analyze Silence charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Silence Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Silence Therapeutics PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Silence Therapeutics PLC based on widely used predictive technical indicators. In general, we focus on analyzing Silence Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Silence Therapeutics's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Silence Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Silence Therapeutics, we also check how macroeconomic factors affect Silence Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding249.52361.683.283.12
PTB Ratio61.3818.3929.7131.2
Hype
Prediction
LowEstimatedHigh
0.165.9111.66
Details
Intrinsic
Valuation
LowRealHigh
6.4915.2220.97
Details
6 Analysts
Consensus
LowTargetHigh
35.9739.5343.88
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.44-0.23-0.11
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Silence Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Silence Therapeutics' short interest history, or implied volatility extrapolated from Silence Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Casinos Idea
Casinos
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Momentum Idea
Momentum
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
When determining whether Silence Therapeutics PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Silence Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Silence Therapeutics Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Silence Therapeutics Plc Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silence Therapeutics. If investors know Silence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silence Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.69)
Revenue Per Share
0.429
Quarterly Revenue Growth
(0.93)
Return On Assets
(0.22)
Return On Equity
(0.64)
The market value of Silence Therapeutics PLC is measured differently than its book value, which is the value of Silence that is recorded on the company's balance sheet. Investors also form their own opinion of Silence Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silence Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silence Therapeutics' market value can be influenced by many factors that don't directly affect Silence Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silence Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.